# Healthy Volunteer Study Using 3 Different Formulations of Firategrast

> **NCT01416363** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 38 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting

## Interventions

- **DRUG:** Firategrast immediate release tablet
- **DRUG:** Firategrast modified release tablet
- **DRUG:** Firategrast gastro-retentive solution

## Key facts

- **NCT ID:** NCT01416363
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05-20
- **Primary completion:** 2011-09-17
- **Final completion:** 2011-09-17
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2017-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01416363

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01416363, "Healthy Volunteer Study Using 3 Different Formulations of Firategrast". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01416363. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*